PMU37 Influence of Patient Population & HTA Assessment on Price Erosion Due to Indication Expansion in Europe: Evaluation across Oncology & NON-Oncology Biopharmaceutical Innovations.
2021
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI